Although cancer immunotherapy has transformed treatment by harnessing the immune system to eliminate tumors, only a small ...
The open-label, single-arm study enrolled 23 adult patients undergoing their first kidney transplant from either living or ...
GeoVax believes Gedeptin’s unique mechanism of localized tumor destruction combined with immune activation positions the program within a growing area of oncology focus: therapies designed to overcome ...
A pan-cancer analysis of 2,930 patients across 11 tumor types found that ALK mutation was associated with significantly ...
This Research Topic is one volume within the series "The Future of Checkpoint Immunotherapy: New Roads Ahead". Please see the ...
Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into a suppressed state. This previously unrecognized molecular interaction, ...
The timing of myocarditis onset during immunotherapy treatment for cancer may predict how likely a person is to die of the condition, according to retrospective study results.Patients who developed my ...
Researchers at MD Anderson have identified RNase H2 as a key survival mechanism in triple-negative breast cancer, helping ...
New study reveals ALK mutation enhances tumor immunogenicity and predicts favorable outcomes in immune checkpoint blockade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results